MedTrace Logo

Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia

NCT01018199 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-02-03

No results posted yet for this study

Summary

In this study the investigators aim to test if C-reactive protein (CRP) or procalcitonin(PCT) - guided strategy allows to reduce the antibiotic use in patients wiht community-acquired pneumonia. Therefore, the safety of this intervention will be carefully measured.

Conditions

  • Community-acquired Pneumonia

Interventions

OTHER

CRP

C-reactive protein guided antibiotic therapy plasma CRP measurement to guide the duration of antibiotic therapy

OTHER

PCT

Procalcitonin guided antibiotic therapy plasma PCT measurement to guide the duration of antibiotic therapy

Sponsors & Collaborators

  • Federal University of Minas Gerais

    lead OTHER

Principal Investigators

  • Vandack A Nobre, PhD · Medical School of the Federal University of Minas Gerais

  • Karla F Finotti, MD · Medical School of the Federal University of Minas Gerais

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01018199 on ClinicalTrials.gov